Treatment of Primary Autoimmune Cerebellar Ataxia with Mycophenolate

por Hadjivassiliou, M., Grunewald, R. A., Shanmugarajah, P. D., Sarrigiannis, P. G., Zis, P., Skarlatou, V., Hoggard, N.
Publicado 2020

Clinical Characteristics and Management of 50 Patients with Anti-GAD Ataxia: Gluten-Free Diet Has a Major Impact

por Hadjivassiliou, M., Sarrigiannis, P. G., Shanmugarajah, P. D., Sanders, D. S., Grünewald, R. A., Zis, P., Hoggard, N.
Publicado 2020

Analysis of brain and spinal MRI measures in a common domain to investigate directional neurodegeneration in motor neuron disease

por Toh, C., Keslake, A., Payne, T., Onwuegbuzie, A., Harding, J., Baster, K., Hoggard, N., Shaw, P. J., Wilkinson, I. D., Jenkins, T. M.
Publicado 2022

Brain haemosiderin in older people: pathological evidence for an ischaemic origin of magnetic resonance imaging (MRI) microbleeds

por Janaway, B M, Simpson, J E, Hoggard, N, Highley, J R, Forster, G, Drew, D, Gebril, O H, Matthews, F E, Brayne, C, Wharton, S B, Ince, P G
Publicado 2014

Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study

por Payne, Thomas, Sassani, Matilde, Buckley, Ellen, Moll, Sarah, Anton, Adriana, Appleby, Matthew, Maru, Seema, Taylor, Rosie, McNeill, Alisdair, Hoggard, N, Mazza, Claudia, Wilkinson, Iain D, Jenkins, Thomas, Foltynie, Thomas, Bandmann, O
Publicado 2020